Author: Branwen Brockley
-
Aleksandra Janowska awarded Postgraduate Student Thesis Prize
Aleksandra Janowska has won this year’s Postgraduate Student Thesis Prize. The Prize is awarded each year to a student who has undertaken an outstanding project to the highest standards during the course of their PhD study.
Find out more -
Pioneering trial offers hope on world pancreatic cancer day
An early-stage trial at Addenbrooke’s Hospital, aims to improve treatment for people with late-stage pancreatic cancer, a challenging cancer that is often diagnosed late, when few treatment options are available.
Find out more -
Institute scientists uncover molecular switch that drives pancreatic cancer progressionÂ
New research from our Carroll Group has identified a molecular mechanism that helps explain how pancreatic ductal adenocarcinoma progresses, offering a potential path toward more targeted treatments.Â
Find out more -
Scientists to Shine a Light on Cancer Research at Inspirational Night Walk
Dr Shalini Rao, a Senior Research Associate at the Cancer Research UK Cambridge Institute, will join postgraduate students Marleen Wolke and Josephine Greenall-Ota for the Shine Night Walk on Saturday, 18 October.
Find out more -
Prof Greg Hannon shortlisted for prestigious Cancer Grand Challenge
The shortlist of 12 multidisciplinary, global teams is now competing for up to ÂŁ20m each, with the aim of delivering breakthroughs that no single researcher, lab, institute or country could achieve alone.Â
Find out more -
Future scientists join our second Cambridge LaunchPad project day
Students from Thomas Clarkson Academy in Wisbech joined us for a unique opportunity to experience the world of cancer research first-hand.
-
Single-cell study sheds new light on why ovarian cancer becomes resistant to chemotherapy
Researchers at the Cancer Research UK Cambridge Institute and Stanford University have mapped how ovarian cancer cells respond to chemotherapy at an unprecedented level of detail, offering new insights into why treatment resistance develops.
-
New clue discovered for why some cancer drugs fall shortÂ
Hedgehog signalling plays a key role in controlling how immune cells migrate into tumours, a discovery that may explain why some cancer drugs have underperformed in clinical trials.Â
Read more -
Dr Jane Gray made guest of honour at Race for Life
The Cambridge Institute scientist, who is currently undergoing treatment for breast cancer, took part in this year's race, inspiring thousands with her story of resilience and hope.
Read more